Thus, there is greater conversion of kynurenine (KYN) into its final product, QA, increasing the production of this neurotoxic metabolite and, indirectly, decreasing KYN bioavailability for the production of the neuroprotective metabolite, kynurenic acid (KynA) (Heisler and OConnor 2015)
Current Market Situation and Future Trends Current market situation At present, this tablet is mainly targeted at scientific research institutions and biotechnology companies, and is used for research in fields such as inflammatory bowel disease, multiple sclerosis, and wound healing.As it has not obtained drug approval, the market size is relatively small, but the demand is on the rise
Direct glutathione supplementation: An RCT in India randomized 206 people with type 2 diabetes (aged 31-78, HbA1c 7.1-9.7%) to receive either 500 mg glutathione daily alongside antidiabetic medications for 6 months, or antidiabetic medications alone
+ Swiss medicine regulator warns against purchase of fake Ozempic The Swiss regulator has analysed Lemon Bottle samples injected into adipose tissue (body fat) from various sources
